Documents Technical Advances

1.  2. Introduction to CISH Chromogenic In Situ Hybridization. Uses chromogen(digoxigenin)-labeled DNA Probes. Allows visualization of cellular DNA and can be performed…

Health & Medicine Perjeta

1.PERJETA® is a first-line treatment for HER2positive metastatic breast cancer. • PERJETA is an FDA-approved treatment for HER2-positive metastatic breast cancer. It is…